Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Armstrong

Showing results (91-100 of 125) with videos related to

Pageof 13
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 30, 2018
Development of Breast Cancer Choices: a decision support tool for young women with breast cancer deciding whether to have genetic testing for BRCA1/2 mutationsChloe Grimmett, Charlotte Brooks, Alejandra Recio-Saucedo, et al.
The Permanente Journal|August 8, 2022
Disparities in the Incidence of Ectopic Pregnancy in a Large Health Care System in California, 2010-2019Tina Raine-Bennett, Michael J Fassett, Malini Chandra, et al.
Clinical Breast Cancer|January 9, 2025
Development and Evaluation of a Remote Monitoring Regional Adjuvant Abemaciclib Service for Patients With High-Risk Early Breast CancerNicole L Brown, Ann Tivey, Suzanne Frank, et al.
Gynecologic Oncology|March 9, 2020
Feasibility, patient compliance and acceptability of ovarian cancer surveillance using two serum biomarkers and Risk of Ovarian Cancer Algorithm compared to standard ultrasound and CA 125 among women with BRCA mutationsReina Haque, Steven J Skates, Mary Anne Armstrong, et al.
European Journal of Cancer (Oxford, England : 1990)|March 9, 2023
OlympiAD extended follow-up for overall survival and safety: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancerMark E Robson, Seock-Ah Im, Elzbieta Senkus, et al.
Gastrointestinal Endoscopy|August 28, 2017
Diagnosis and predictors of sessile serrated adenoma after educational training in a large, community-based, integrated healthcare settingDan Li, John Woolfrey, Sheng-Fang Jiang, et al.
Gynecologic Oncology|October 5, 2020
Development of a longitudinal two-biomarker algorithm for early detection of ovarian cancer in women with BRCA mutationsScott E Lentz, C Bethan Powell, Reina Haque, et al.
The New England Journal of Medicine|June 6, 2017
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA MutationMark Robson, Seock-Ah Im, Elżbieta Senkus, et al.
Patient Education and Counseling|December 12, 2017
Systematic review of the empirical investigation of resources to support decision-making regarding BRCA1 and BRCA2 genetic testing in women with breast cancerChloe Grimmett, Karen Pickett, Jonathan Shepherd, et al.
Contraception|September 21, 2021
Ectopic pregnancy prevention: Further evidence of benefits of prescription contraceptivesTina Raine-Bennett, Michael J Fassett, Malini Chandra, et al.
Pageof 13

Showing results (91-100 of 125) with videos related to

Sort By:
Pageof 13
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 30, 2018
Development of Breast Cancer Choices: a decision support tool for young women with breast cancer deciding whether to have genetic testing for BRCA1/2 mutationsChloe Grimmett, Charlotte Brooks, Alejandra Recio-Saucedo, et al.
The Permanente Journal|August 8, 2022
Disparities in the Incidence of Ectopic Pregnancy in a Large Health Care System in California, 2010-2019Tina Raine-Bennett, Michael J Fassett, Malini Chandra, et al.
Clinical Breast Cancer|January 9, 2025
Development and Evaluation of a Remote Monitoring Regional Adjuvant Abemaciclib Service for Patients With High-Risk Early Breast CancerNicole L Brown, Ann Tivey, Suzanne Frank, et al.
Gynecologic Oncology|March 9, 2020
Feasibility, patient compliance and acceptability of ovarian cancer surveillance using two serum biomarkers and Risk of Ovarian Cancer Algorithm compared to standard ultrasound and CA 125 among women with BRCA mutationsReina Haque, Steven J Skates, Mary Anne Armstrong, et al.
European Journal of Cancer (Oxford, England : 1990)|March 9, 2023
OlympiAD extended follow-up for overall survival and safety: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancerMark E Robson, Seock-Ah Im, Elzbieta Senkus, et al.
Gastrointestinal Endoscopy|August 28, 2017
Diagnosis and predictors of sessile serrated adenoma after educational training in a large, community-based, integrated healthcare settingDan Li, John Woolfrey, Sheng-Fang Jiang, et al.
Gynecologic Oncology|October 5, 2020
Development of a longitudinal two-biomarker algorithm for early detection of ovarian cancer in women with BRCA mutationsScott E Lentz, C Bethan Powell, Reina Haque, et al.
The New England Journal of Medicine|June 6, 2017
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA MutationMark Robson, Seock-Ah Im, Elżbieta Senkus, et al.
Patient Education and Counseling|December 12, 2017
Systematic review of the empirical investigation of resources to support decision-making regarding BRCA1 and BRCA2 genetic testing in women with breast cancerChloe Grimmett, Karen Pickett, Jonathan Shepherd, et al.
Contraception|September 21, 2021
Ectopic pregnancy prevention: Further evidence of benefits of prescription contraceptivesTina Raine-Bennett, Michael J Fassett, Malini Chandra, et al.
Pageof 13